These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


86 related items for PubMed ID: 7364917

  • 21. A specific HPLC method for determination of beta-blockers topically used in ophthalmological diseases.
    Tracqui A, Kintz P, Himber J, Lugnier AA, Mangin P.
    Forensic Sci Int; 1988; 38(1-2):37-41. PubMed ID: 2903842
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Hemodynamics in patients with coronary heart disease under conditions of physical exercise before and after mepindolol-sulfate (author's transl)].
    Bonelli J, Magometschnigg D, Hitzenberger G, Kaik G.
    Z Kardiol; 1978 Jan; 67(1):51-6. PubMed ID: 343414
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. In vitro evaluation of the beta-blocking and electrophysiological properties of mepindolol.
    Amerini S, Bini R, Cerbai E, Ledda F, Mantelli L, Mugelli A.
    Arch Int Pharmacodyn Ther; 1986 Aug; 282(2):276-87. PubMed ID: 2876690
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Multicenter evaluation of mepindolol and of mepindolol plus hydrochlorothiazide in essential hypertension.
    Masoni A, Galassi A, Ginevrino P, Libretti A, Morgagni W, Rappelli A, Tomasi AM.
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):546-50. PubMed ID: 6757152
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. HPLC determination of 5-hydroxypropafenone in plasma with electrochemical detection.
    Brode E, Kripp U, Breckwoldt W.
    Methods Find Exp Clin Pharmacol; 1988 May; 10(5):319-29. PubMed ID: 3398648
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparative investigation of the respiratory and cardiovascular effect of mepindolol, propranolol and pindolol in asthmatic patients.
    Beumer HM, Teirlinck C, Wiseman RA.
    Int J Clin Pharmacol Biopharm; 1978 Jun; 16(6):249-53. PubMed ID: 27463
    [Abstract] [Full Text] [Related]

  • 38. Simultaneous determination of thirteen beta-blockers and one metabolite by gradient high-performance liquid chromatography with photodiode-array UV detection.
    Delamoye M, Duverneuil C, Paraire F, de Mazancourt P, Alvarez JC.
    Forensic Sci Int; 2004 Apr 20; 141(1):23-31. PubMed ID: 15066710
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Determination of Org NC 45 (a myoneural blocking agent) in human plasma using high-performance normal-phase liquid chromatography.
    Paanakker JE, van de Laar GL.
    J Chromatogr; 1980 Oct 10; 183(4):459-66. PubMed ID: 6107302
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.